University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
UCSF's novel approach to a therapeutic cancer vaccine may provide a new option for patients relapsing with AML

UCSF's novel approach to a therapeutic cancer vaccine may provide a new option for patients relapsing with AML

February 11, 2019

An experimental cancer vaccine in early-stage development at the University of California San Francisco has sparked hope that patients with acute myeloid leukemia (AML), an aggressive cancer of the blood, could one day have a life-saving alternative, especially those prone to relapse or unable to ...
Q & A with Thea Tlsty, PhD, on Leading International Team to Study Inflammation and Cancer

Q & A with Thea Tlsty, PhD, on Leading International Team to Study Inflammation and Cancer

January 29, 2019

Thea D. Tlsty, PhD, Professor of Pathology and a UCSF leader in cell cycling and signaling, received a $26 million Grand Challenge Grant from Cancer Research UK (CRUK) to lead an international team exploring how chronic inflammation causes cancer. 

Common Pain Reliever Can Improve Survival in Head and Neck Cancer

Common Pain Reliever Can Improve Survival in Head and Neck Cancer

January 24, 2019

Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found.  Non-steroidal anti-inflammatory drugs, or NSAIDs, improved the overall ...
$26 Million 'Grand Challenge' Project Will Probe Role of Inflammation in Cancer

$26 Million 'Grand Challenge' Project Will Probe Role of Inflammation in Cancer

January 23, 2019

“The Grand Challenge is designed to address really big, intractable questions in cancer. The idea is not to make small, incremental steps, but to make a huge leap forward.” Thea Tlsty, PhD Related news:Q & A with Thea Tlsty, PhD, on Leading International ...
Drug Hobbles Deadly Liver Cancer by Stifling Protein Production

Drug Hobbles Deadly Liver Cancer by Stifling Protein Production

January 14, 2019

In laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach. Traditionally, targeted cancer therapies aim to disable proteins borne of cancer-driving genes. Instead, the UCSF scientists prevented these proteins, including those that shield tumors ...
Divide and Conquer: UCSF Cancer Team Finds Promise in Precision Medicine Approach to Osteosarcoma

Divide and Conquer: UCSF Cancer Team Finds Promise in Precision Medicine Approach to Osteosarcoma

January 9, 2019

Using a divide and conquer strategy, researchers from the University of California San Francisco have provided a road map for the development of a precision medicine approach to osteosarcoma, the most common bone cancer in children and young adults and an aggressive disease for ...
Radiation Dose in CT Scans Varies Due to Scanners' Technical Settings

Radiation Dose in CT Scans Varies Due to Scanners' Technical Settings

January 8, 2019

The amount of radiation that patients are exposed to from computed tomography (CT) scans varies widely between institutions and countries, and is largely due to differences in the technical settings of the scanning machines at each institution, according to an international study led by ...
Landmark Mammography Study Highlights the Importance of Breast Cancer Screening

Landmark Mammography Study Highlights the Importance of Breast Cancer Screening

December 26, 2018

A landmark mammography study has found that women who receive annual breast cancer screenings will have a lower mortality rate and will benefit more from therapy upon diagnosis of breast cancer. The lead investigator on this study was László Tabár, MD. He and his ...
Faculty Ideas Inspire Record-Breaking Year for UCSF's Campaign

Faculty Ideas Inspire Record-Breaking Year for UCSF's Campaign

December 23, 2018

In the year since announcing an ambitious, $5 billion fundraising campaign, UC San Francisco has seen record-breaking generosity from its supporters, inspired by faculty-led ideas to tackle some of the toughest problems in health and science. See More of UCSF’s 2018 Year in Review » ...
Prostate Cancer Disparities Greatest in Low-Risk Disease

Prostate Cancer Disparities Greatest in Low-Risk Disease

December 19, 2018

Black men in the United States are known to suffer disproportionately from prostate cancer. Now, a new study investigating prostate cancer deaths by race has found that African American men have twice the chance of dying from low-risk prostate cancer than men of other racial ...